Aclaris Therapeutics, Inc. Inventory
Aclaris Therapeutics, Inc. (ACRS) had Inventory of $0 as of 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2020-02-25
- 2019-12-31: Inventory, Net $0.00.
- 2019-09-30: Inventory, Net $189.00K.
- 2019-06-30: Inventory, Net $185.00K.
- 2019-03-31: Inventory, Net $856.00K.
| Period end | Inventory, Net |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-02-25 |
| 2019-09-30 | $189.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $185.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $856.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $791.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | $1.04M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.03M 10-Q · filed 2018-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |